Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-03-03 Griffin Deborah A Chief Accounting Officer Option exercise +1,166 4,107
2019-03-03 Griffin Deborah A Chief Accounting Officer Option exercise · Restricted Share Units −1,166 2,332
2019-03-03 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise +1,399 8,663.7
2019-03-03 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise · Restricted Share Units −1,399 2,799
2019-03-03 Daniell Richard Exec. VP, European Commercial Option exercise +2,098 2,098
2019-03-03 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −2,098 4,199
2019-03-02 Griffin Deborah A Chief Accounting Officer Option exercise +2,941 2,941
2019-03-02 Griffin Deborah A Chief Accounting Officer Option exercise · Restricted Share Units −2,941 8,823
2019-02-14 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +3,926 6,900.39
2019-02-14 Stark David Matthew Exec. VP Chief Legal Officer Sale −3,926 $17.74 $70K 2,974.39
2019-02-14 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −3,926 7,852
2019-02-14 Sabag Mark EVP, Global Human Resources Option exercise +5,710 56,607.54
2019-02-14 Sabag Mark EVP, Global Human Resources Option exercise · Restricted Share Units −5,710 11,422
2019-02-14 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +5,353 17,178.51
2019-02-14 Fridriksdottir Hafrun Executive VP, Global R&D Sale −1,841 $17.67 $33K 15,337.51
2019-02-14 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −5,353 10,708
2019-02-14 de Notaristefani Carlo Executive VP Global Operations Option exercise +9,280 21,400.73
2019-02-14 de Notaristefani Carlo Executive VP Global Operations Sale −3,192 $17.67 $56K 18,208.73
2019-02-14 de Notaristefani Carlo Executive VP Global Operations Option exercise · Restricted Share Units −9,280 18,560
2019-02-14 Codner Iris Beck EVP Global Brand&Communication Option exercise +3,212 17,996.04

Page 68 of 76 · 1,517 trades